JPRN-UMIN000028150招募中未知
Analysis of apolipoprotein A2 isoform as a novel pancreatic exocrine marker - Analysis of apolipoprotein A2 isoform as a novel pancreatic exocrine marker
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1.Normal Volunteers: Exclusion criteria are as follows. 1: Cases where pancreatic diseases are merged. 2: In case of internal medication treatment. In the case of 3: Example of impaired renal function. 4: Example of acute hepatitis. 5: Case of alcohol sensitivity. 2.Patients with chronic pancreatitis: There is no special exclusion criteria. 3.fat - water MRI: Exclusion criteria are not specifically provided.
研究者
相似试验
尚未招募
3 期
Effect of Shilajatu Darvi Yoga on plasma expression of Apolipoprotein A-IV (ApoA-IV) and Thioredoxin interacting protein (TXNIP) in the patients of Madhumeha (Type 2 Diabetes Mellitus).CTRI/2024/01/061750Prof Dr Tanuja Nesari
招募中
不适用
A Study of the Prevalence of Apolipoprotein L1(APOL1) Alleles Among Individuals With Proteinuric Kidney Disease Who Are of Recent African Ancestry or Geographic OrigiProteinuric Kidney Disease10038360NL-OMON51493Vertex Pharmaceuticals20
尚未招募
不适用
A substudy of the PLAPCI trial comparing Phospholipase A2 release with tissue characteristics as determined by invasive ultrasound and infrared imaging of the heart arteries in patients with coronary artery disease undergoing coronary artery stenting.Coronary artery diseaseCardiovascular - Coronary heart diseaseACTRN12611000869976Sir Charles Gairdner Hospital50
尚未招募
1 期
Apolipoprotein E driven therapeutics for Alzheimer’s diseaseAlzheimer's DiseaseACTRN12613000465752uclear Medicine and Centre for PET Research Fund20
尚未招募
不适用
Antiphospholipid Antibody (APLA) level in COVID-19 Cases.CTRI/2020/06/026118DR Rajlaxmi Sarangi